2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

ETF spelt out with a rising green arrow.
ETFs

3 amazing ASX ETFs that focus on quality

Looking for ETFs to buy? Here are three high-quality picks to consider.

Read more »

Graphic showing yellow arrow above vertical columns indicating a rising share price
Share Market News

$10,000 invested in this ASX ETF a month ago is now worth $14,500

Investors in this ASX ETF are sitting on very appealing short-term gains.

Read more »

A girl sits on her bed in her room while using laptop and listening to headphones.
ETFs

3 Betashares ETFs I'd buy and hold for 10 years

If you’re investing for the next decade, simplicity matters. Here are three ETFs I’d consider.

Read more »

A woman sits at her desk thinking. She is surrounded by projections of world maps on various screens with data appearing below them.
ETFs

These 3 ASX ETFs can help protect your portfolio in 2026

The US isn't looking quite as appealing as it did...

Read more »

A young woman with a ponytail stands at the crossroads, trying to choose between one way or the other.
ETFs

Portfolio strategies for 2 potential Middle East scenarios – Expert

Which ASX ETFs should investors be targeting in the current environment?

Read more »

A man sees some good news on his phone and gives a little cheer.
ETFs

3 exciting ASX ETFs for Aussie growth investors to buy and hold

These shares offer exposure to exciting areas of the share market.

Read more »

a man with his back facing the camera sits at a computer displaying a screen of code with an electric power contraption on the desk near him as he sits in concentration while appearing to mine cryptocurrency.
ETFs

The compelling case for this cybersecurity ASX ETF

The current geopolitical climate could lead to tailwinds for this fund.

Read more »

Man looking at an ETF diagram.
ETFs

2 excellent ASX ETFs I rate as buys in March

These investments appeal to me as great options for long-term returns.

Read more »